Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Pharmaceutical and Biomedical Analysis|November 14, 2025
Development of an LC-MS/MS method for the quantification of sunitinib and its metabolites in human nail and skinMiki Takenaka Sato, Takuya Araki, Hideaki Yashima, et al.
Oncology Reports|February 15, 2011
Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinomaYohei Miyamae, Kimihiro Shimizu, Junko Hirato, et al.
Cancer Chemotherapy and Pharmacology|December 26, 2024
Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatmentMiki Takenaka Sato, Takuya Araki, Hideaki Yashima, et al.
Journal of Medicinal Chemistry|August 25, 2012
Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activityMitsuhiro Arisawa, Yayoi Kasaya, Tohru Obata, et al.
The Journal of Molecular Diagnostics : JMD|January 23, 2010
Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissueYohei Miyamae, Kimihiro Shimizu, Yasumasa Mitani, et al.
Anesthesiology|December 20, 2022
Prevention of Postoperative Cognitive Dysfunction by Minocycline in Elderly Patients after Total Knee Arthroplasty: A Randomized, Double-blind, Placebo-controlled Clinical TrialTomonori Takazawa, Tatsuo Horiuchi, Masaki Orihara, et al.
Thrombosis Research|August 16, 2016
Factors influencing trough and 90-minute plasma dabigatran etexilate concentrations among patients with non-valvular atrial fibrillationHideharu Tomita, Takuya Araki, Toshiaki Kadokami, et al.
The Journal of Molecular Diagnostics : JMD|December 17, 2009
Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methodsTakuya Araki, Kimihiro Shimizu, Katsunori Nakamura, et al.
Cancer Medicine|May 27, 2016
Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinomaYasuaki Enokida, Kimihiro Shimizu, Jun Atsumi, et al.
Oncology Reports|July 20, 2011
Clinical screening assay for EGFR exon 19 mutations using PNA-clamp smart amplification process version 2 in lung adenocarcinomaTakuya Araki, Kimihiro Shimizu, Tomonori Nakamura, et al.
Pageof 6